Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Study suggests that antidepressants could also be used for the treatment of amblyopia

In the April 18 issue of Science, scientists from the Scuola Normale Superiore in Pisa, Italy and the Neuroscience Centre at the University of Helsinki, Finland, provide new information about the mechanism of action of antidepressant drugs.

17 Apr 2008

20 percent of Iraq and Afghanistan veterans suffer from PTSD or major depression

Nearly 20 percent of military service members who have returned from Iraq and Afghanistan - 300,000 in all - report symptoms of post traumatic stress disorder or major depression, yet only slight more than half have sought treatment, according to a new RAND Corporation study.

17 Apr 2008

Measurement technology to investigate neurovascular coupling

Every two minutes in Germany, one person suffers a stroke. About one third of the affected do not survive the sudden lack of blood in the brain, many others are left with serious disabilities.

17 Apr 2008

Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment

Aerobic exercise could give older adults a boost in brainpower, according to a recent review of studies from the Netherlands.

17 Apr 2008

Heavy drinkers and smokers develop Alzheimer's earlier

Heavy drinkers and heavy smokers develop Alzheimer's disease years earlier than people with Alzheimer's who do not drink or smoke heavily, according to research that will be presented at the American Academy of Neurology 60th Anniversary Annual Meeting in Chicago, April 12-19, 2008.

17 Apr 2008

Wild Mediterranean plant provides potential anticancer medicines

A group of scientists from the Department of Organic Chemistry and the Biotechnology Institute of the University of Granada have found out that the plant “Dittirichia viscose”, known as elecampe, can be used to obtain inhibitors of neurogenic vasodilatation, a significant progress in migraine and cancer treatments.

17 Apr 2008

New hybrid hearing aid/cochlear implant device

A new hybrid hearing aid/cochlear implant device designed for patients who can benefit from both is being evaluated by UT Southwestern Medical Center otolaryngologists, as part of a multisite, national study.

17 Apr 2008

2nd Alzheimer's vaccine by AFFiRiS

The Viennese biotech company Affiris is today taking stock of the progress achieved to date in its clinical Alzheimer's vaccination programme. All the Alzheimer's patients treated so far as part of the toxicological trials have tolerated the treatment extremely well. As a result, Affiris is among the leading international centres in the race to develop the first causal immunotherapy for Alzheimer's disease.

17 Apr 2008

New drug for melanoma riluzole shows promise

Rutgers Professor Suzie Chen has found that riluzole, a U.S. Food and Drug Administration (FDA) approved drug used to treat Lou Gehrig's disease (ALS), slows the growth of melanoma, the most aggressive form of malignant skin cancer.

16 Apr 2008

Drugs in the pipeline: new therapies that could change treatment strategies

The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.

16 Apr 2008

Exposure to organic solvents linked to disturbances in brain circuitry

Chronic occupational exposure to organic solvents, found in materials such as paints, printing and dry cleaning agents, is widespread all over the world, and is thought to damage the central nervous system.

16 Apr 2008

CDC issues measles travel warning for Israel

As Americans travel to Israel for the Jewish holiday of Passover, the Centers for Disease Control and Prevention advises all travelers to ensure they are protected from measles before departing, because of a measles outbreak in Israel.

16 Apr 2008

Promising Australian cancer drug on show in the U.S.

A cancer drug in the process of being developed by two Australian companies has shown promising results in preliminary trials on animals.

16 Apr 2008

What happens in the human brain just before a decision is made?

Already several seconds before we consciously make a decision its outcome can be predicted from unconscious activity in the brain.

15 Apr 2008

How hormone levels affect financial traders

When City traders have high morning testosterone levels they make more than average profits for the rest of that day, researchers at the University of Cambridge have discovered.

15 Apr 2008

Sleeping sickness metabolic 'fingerprint' could lead to earlier diagnosis

Sleeping sickness creates a metabolic 'fingerprint' in the blood and urine, which could enable a new test to be developed to diagnose the disease, according to new research published today in the journal Proceedings of the National Academy of Sciences.

15 Apr 2008

Potential treatment for multiple sclerosis goes to trial

A potential treatment for multiple sclerosis (MS), developed by University of Greenwich in association with Kings College, London, has begun clinical trials.

15 Apr 2008

NovoCure presents results from breast cancer pilot study

NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer.

15 Apr 2008

Stem cell marker controls two key cancer pathways

Researchers at Georgetown University Medical Center have discovered that a gene associated with human breast stem cells can stimulate development of mammary cells by activating two critical cancer pathways.

15 Apr 2008

Elevated levels of antioxidant urate may slow Parkinson's progression

Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson's disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public Health (HSPH) examined data from an earlier study and found that, among recently diagnosed Parkinson's patients, those with the highest urate levels had a significantly slower rate of disease progression during the two-year study period.

15 Apr 2008